首页> 外国专利> MEDICINE CONTAINING DOPAMINE D2-LIKE RECEPTOR AGONIST AS ACTIVE INGREDIENT AND SCREENING METHOD

MEDICINE CONTAINING DOPAMINE D2-LIKE RECEPTOR AGONIST AS ACTIVE INGREDIENT AND SCREENING METHOD

机译:包含多巴胺D2样受体激动剂的药物作为活性成分和筛选方法

摘要

PPROBLEM TO BE SOLVED: To provide a medicine effective for a disease (e.g. multiple sclerosis) caused by the excessive reaction of Th2 or Th17 of a helper T cell, and to provide an effective screening method of the medicine. PSOLUTION: The medicine for treating or preventing the disease caused by the excessive reaction of the Th2 or the Th17 contains a dopamine D2-like receptor agonist as an active ingredient. The screening method of the medicine uses the bond to the dopamine D2-like receptor and/or the active effect on the dopamine D2-like receptor as an indicator. Especially, at least one of pramipexole hydrochloride hydrate and ropinirole hydrochloride is preferable as the medicine. PCOPYRIGHT: (C)2010,JPO&INPIT
机译:<要解决的问题:提供对由辅助T细胞的Th2或Th17的过度反应引起的疾病(例如多发性硬化)有效的药物,并提供有效的药物筛选方法。

解决方案:用于治疗或预防由Th2或Th17过度反应引起的疾病的药物包含多巴胺D2样受体激动剂作为有效成分。药物的筛选方法以与多巴胺D2样受体的键和/或对多巴胺D2样受体的活性为指标。其中,优选盐酸普拉克索水合物和盐酸罗匹尼罗中的至少一种作为药物。

版权:(C)2010,日本特许厅&INPIT

著录项

  • 公开/公告号JP2010111581A

    专利类型

  • 公开/公告日2010-05-20

    原文格式PDF

  • 申请/专利权人 IMUNO:KK;SAITAMA MEDICAL UNIV;

    申请/专利号JP20070014786

  • 发明设计人 MATSUSHITA SHO;NAKANO KAZUHISA;

    申请日2007-01-25

  • 分类号A61K45;A61P43;A61K31/4045;A61K31/428;A61P25;A61P19/02;A61P29;A61P37/06;A61P21;A61P11/06;A61P37/08;A61P17;A61P3/10;A61P13/12;G01N33/15;G01N33/50;

  • 国家 JP

  • 入库时间 2022-08-21 19:05:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号